Anthracycline-induced cardiotoxicity: A case report and review of literature

CONCLUSION: We present a case of 35-year-old African American female developing cardiogenic shock shortly after receiving a cumulative dose of 450 mg/m2 doxorubicin over 9 mo. Cardiac monitoring and management of patients receiving anthracycline chemotherapy have been an area of intense research since introduction of these agents in clinical practice. We have reviewed literature and recent advances in the prediction and prevention of AIC. Although risk factors currently identified can help stratify patients who need closer monitoring, there are limitations to our current understanding and further research is needed in this field.PMID:33552401 | PMC:PMC7821007 | DOI:10.4330/wjc.v13.i1.28
Source: World Journal of Cardiology - Category: Cardiology Authors: Source Type: research